Acute Myeloid Leukemia in Children Clinical Trial
Official title:
A Food Effect Phase I Study of the Clifutinib in Healthy Subjects
The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 40 mg Clifutinib in healthy subjects.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05792007 -
Study of the Medullary Microenvironment in Acute Childhood Leukemia
|
N/A | |
Recruiting |
NCT03068819 -
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
|
Phase 1/Phase 2 | |
Completed |
NCT03389724 -
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
|
Phase 3 | |
Not yet recruiting |
NCT06421155 -
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
|
N/A | |
Recruiting |
NCT05994690 -
CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients
|
Phase 3 | |
Recruiting |
NCT06233526 -
Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test
|
N/A | |
Recruiting |
NCT06262438 -
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
|
Phase 2 |